Healthcare and life sciences is a robust market. Though it’s not immune to the economic and geopolitical headwinds affecting all industries, its underlying strength will continue to promote dealmaking.
Global Deal Outlook
We are delighted to launch the fifth edition of the Global Transactions Forecast, developed in conjunction with Oxford Economics. In the current report, we offer investors and corporations alike an overview of the latest global deals landscape, including predictions for M&A and IPO activity during 2020-2022, and a closer look at the macroeconomic and financial drivers that underpin projections of transactional appetite globally and regionally. Please read the report above and contact us with any questions.
2020 Deal Soundbites
Hear the top key insights of the report, brought to you by Ai Ai Wong, our Global Transaction Leader, Koen Vanhaerents, Global Head of Capital Markets, and Rod Hunter, international trade partner in our Washington DC office.
You can also zoom in on specific, dealmaking drivers for 42 countries around the world. Glance at their macroeconomic and financial performance. Then, compare and contrast their global attractiveness for M&A and IPO activity. Please click on the regions and individual country links below.
We do more cross-border transactions than any other law firm in the world, and are ranked the number one law firm in cross-border deals by volume over the past decade.
We use cookies to improve your experience on our website. To find out more about the cookies we use and how to change your settings if you do not want cookies to be placed on your device, please read our Privacy and Cookies Statement.